A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer
Ontology highlight
ABSTRACT: Interventions: investigational material(s)
Generic name etc : OCV-C02
INN of investigational material : -
Therapeutic category code : 42- Antineoplastic agents
Dosage and Administration for Investigational material : Once-weekly subcutaneous injection (0.3, 1 3 and 6 mg/body)
control material(s)
Generic name etc : -
INN of investigational material : -
Therapeutic category code :
Dosage and Administration for Investigational material : -
Primary outcome(s): safety
Dose Limiting Toxicity (DLT)
Common Terminology Criteria for Adverse Events (CTCAE), ver. 4.0
Study Design: multicenter, open, non-comparative study
DISEASE(S): Advanced Or Relapsed Colorectal Cancer
PROVIDER: 100907 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA